Social Pharmacy Journal (SPJ)

Published by: Kowsar

Using Terazosin to Treat Methadone Associated Excessive Sweating: A Case Series Study

Arvin Hedayati 1 , * and Ahmad Ghanizadeh 1
Authors Information
1 Department of Psychiatry, Fasa University of Medical Sciences, Fasa, IR Iran
Article information
  • Social Pharmacy Journal (SPJ): March 2016, 1 (1); e3822
  • Published Online: March 21, 2016
  • Article Type: Case Report
  • Received: January 17, 2015
  • Accepted: March 14, 2015

To Cite: Hedayati A, Ghanizadeh A. Using Terazosin to Treat Methadone Associated Excessive Sweating: A Case Series Study, Soc Pharm J. 2016 ; 1(1):e3822.

Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Cases Presentation
3. Discussion
  • 1. Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004; 19(8): 565-76[DOI][PubMed]
  • 2. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009; (3)[DOI][PubMed]
  • 3. Bilban M, Bilban Jakopin C. Methadone maintenance treatment and drugs. Coll Antropol. 2002; 26(1): 107-17[PubMed]
  • 4. Trussell RE, Gollance H. Methadone maintenance treatment is successful for heroin addicts. Hosp Manage. 1970; 110(4): 56-62[PubMed]
  • 5. Dole VP, Nyswander M. A Medical Treatment for Diacetylmorphine (Heroin) Addiction. A Clinical Trial with Methadone Hydrochloride. JAMA. 1965; 193: 646-50[PubMed]
  • 6. Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health. 2007; 84(3): 436-54[DOI][PubMed]
  • 7. Willner-Reid J, Belendiuk KA, Epstein DH, Schmittner J, Preston KL. Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat. 2008; 35(1): 78-86[DOI][PubMed]
  • 8. Schmittner J, Schroeder JR, Epstein DH, Preston KL. Menstrual cycle length during methadone maintenance. Addiction. 2005; 100(6): 829-36[DOI][PubMed]
  • 9. Fahey T, Law F, Cottee H, Astley P. Sudden death in an adult taking methadone: lessons for general practice. Br J Gen Pract. 2003; 53(491): 471-2[PubMed]
  • 10. Hendra TJ, Gerrish SP, Forrest AR. Fatal methadone overdose. BMJ. 1996; 313(7055): 481-2[PubMed]
  • 11. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003; 23(6): 802-5[PubMed]
  • 12. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002; 137(6): 501-4[PubMed]
  • 13. Ridgway ZA, Pountney AJ. Acute respiratory distress syndrome induced by oral methadone managed with non-invasive ventilation. Emerg Med J. 2007; 24(9): 681[DOI][PubMed]
  • 14. Begre S, von Bardeleben U, Ladewig D, Jaquet-Rochat S, Cosendai-Savary L, Golay KP, et al. Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. J Clin Psychopharmacol. 2002; 22(2): 211-5[PubMed]
  • 15. Moody DE, Fang WB, Lin SN, Weyant DM, Strom SC, Omiecinski CJ. Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes. Drug Metab Dispos. 2009; 37(12): 2323-9[DOI][PubMed]
  • 16. Lemesle F, Lemesle F, Nicola W, Pierre Jonville-Bera A. First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction. Am J Emerg Med. 2010; 28(3): 387 e5-6[DOI][PubMed]
  • 17. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med. 2008; 5(3): 684-92[DOI][PubMed]
  • 18. Langrod J, Lowinson J, Ruiz P. Methadone treatment and physical complaints: a clinical analysis. Int J Addict. 1981; 16(5): 947-52[PubMed]
  • 19. Yaffe GJ, Strelinger RW, Parwatikar S. Physical symptom complaints of patients on methadone maintenance. Proc Natl Conf Methadone Treat. 1973; 1: 507-14[PubMed]
  • 20. Sheridan J, Wheeler A, Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? Harm Reduct J. 2005; 2: 25[DOI][PubMed]
  • 21. Schoofs N, Riemer T, Bald LK, Heinz A, Gallinat J, Bermpohl F, et al. [Methadone and levomethadone - dosage and side effects]. Psychiatr Prax. 2014; 41(2): 82-7[DOI][PubMed]
  • 22. Al-Adwani A, Basu N. Methadone and excessive sweating. Addiction. 2004; 99(2): 259[PubMed]
  • 23. Caflisch C, Figner B, Eich D. Biperiden for excessive sweating from methadone. Am J Psychiatry. 2003; 160(2): 386-7[DOI][PubMed]
  • 24. Lucas AC, Bermejo AM, Tabernero MJ, Fernandez P, Campora P. Influence of concomitant drugs on methadone elimination half-life in patients under a maintenance treatment. Addict Biol. 2001; 6(2): 171-6[DOI][PubMed]
  • 25. Mago R, Thase ME, Rovner BW. Antidepressant-induced excessive sweating: clinical features and treatment with terazosin. Ann Clin Psychiatry. 2013; 25(3): 186-92[PubMed]
  • 26. Ghaleiha A, Shahidi KM, Afzali S, Matinnia N. Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: a randomized controlled trial. Int J Psychiatry Clin Pract. 2013; 17(1): 44-7[DOI][PubMed]
  • 27. Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literature. J Am Board Fam Med. 2012; 25(6): 878-93[DOI][PubMed]
  • 28. Martinez R, Jones D, Hodge D, Buono MJ. Blocking the beta-adrenergic system does not affect sweat gland function during heat acclimation. Auton Neurosci. 2012; 169(2): 113-5[DOI][PubMed]
  • 29. Buono MJ, Tabor B, White A. Localized beta-adrenergic receptor blockade does not affect sweating during exercise. Am J Physiol Regul Integr Comp Physiol. 2011; 300(5)-51[DOI][PubMed]
  • 30. Demling J, Beyer S, Kornhuber J. To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs. Med Hypotheses. 2010; 74(1): 155-7[DOI][PubMed]
  • 31. Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril. 2000; 74(1): 20-3[PubMed]
  • 32. Lepor H, Lepor NE, Hill LA, Trohman RG. The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia. Rev Urol. 2008; 10(2): 85-91[PubMed]
  • 33. Tatari F, Shakeri J, Farnia V, Heidari F, Rezaei M. Bupropion in methadone induced erectile dysfunction. Life Sci J. 2013; 10(9)
  • 34. Nicolai MP, Liem SS, Both S, Pelger RC, Putter H, Schalij MJ, et al. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014; 22(1): 11-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments